MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term notes
receivable, net of allowance...
$4,348,107
Prepaid expenses and
other current assets
$343,091
Cash and cash
equivalents
$38,777,166
Other assets
$2,000
Total current assets
$43,468,364
Total assets
$43,470,364
Total liabilities &
stockholders equity...
$43,470,364
Total stockholders
equity (deficit)
$38,547,078
Total current
liabilities
$4,923,286
Accumulated deficit
-$129,430,981
Additional paid-in capital
$131,809,991
Promissory notes
$2,897,107
Convertible debt
$339,736
Warrant liabilities
$362,323
Accrued expenses and
other current...
$41,896
Accounts payable
$1,282,224
Common stock, 0.001 par
value 225,000,000...
$67,734
Preferred stock, 0.001 par
value 15,000,000...
$36,100,334
Back
Back
Balance Sheet
source: myfinsight.com
Qualigen Therapeutics, Inc. (QLGN)
Qualigen Therapeutics, Inc. (QLGN)